Patents by Inventor Albert Shulman

Albert Shulman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030144271
    Abstract: The present invention relates to methods of therapy for substance addiction comprising the administration to a subject in need thereof a combination of: (i) a &mgr;-opioid receptor antagonist; (ii) a calcium channel blocker which is long-acting or in sustained-release form or which is nimodipine in rapid release form; and (iii) an NMDA glutamate receptor modulator; as well as combinations, kits and composition useful therefor.
    Type: Application
    Filed: November 6, 2002
    Publication date: July 31, 2003
    Inventor: Albert Shulman
  • Patent number: 4004006
    Abstract: This invention discloses the use of chelates formed from transition metals and 1,10-phenanthroline or 2,2'-bypyridine as contraceptives adapted for intravaginal use which also give high protection against venereal disease.Specifically high activity is shown for the copper (I) and copper (II) chelates of the bases, particularly when these are substituted with a number of substituents.
    Type: Grant
    Filed: November 12, 1974
    Date of Patent: January 18, 1977
    Inventors: Albert Shulman, Glenda Maud Shulman